{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T21:20:34Z","timestamp":1777324834998,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jad.2019.11.150","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T08:29:37Z","timestamp":1575275377000},"page":"221-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Atypical immune response to Epstein-Barr virus in major depressive disorder"],"prefix":"10.1016","volume":"264","author":[{"given":"Lorraine","family":"Jones-Brando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faith","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glen","family":"Ford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassie","family":"Stallings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Origoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Katsafanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Squire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Khushalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.11.150_bib0001","first-page":"362","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders","volume":"7","author":"Ambinder","year":"2003","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"10.1016\/j.jad.2019.11.150_bib0002","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1086\/491746","article-title":"Mononucleosis in the laboratory","volume":"192","author":"Ambinder","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jad.2019.11.150_bib0003","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1176\/ajp.143.12.1593","article-title":"Serum antibodies to Epstein-Barr virus in patients with major depressive disorder","volume":"143","author":"Amsterdam","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0004","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jmv.1890430308","article-title":"Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology","volume":"43","author":"Andersson","year":"1994","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0005","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eurpsy.2005.02.008","article-title":"Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis","volume":"21","author":"Behr","year":"2006","journal-title":"Eur. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2019.11.150_bib0006","article-title":"Reconceptualizing major depressive disorder as an infectious disease","volume":"4","author":"Canli","year":"2014","journal-title":"Biol. Mood Anxiety Disord."},{"key":"10.1016\/j.jad.2019.11.150_bib0007","doi-asserted-by":"crossref","first-page":"19141","DOI":"10.1002\/jcp.28641","article-title":"Thyroid autoimmune diseases and thyroid tumors: would EBV infection be the link?","volume":"234","author":"de Almeida","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.jad.2019.11.150_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","article-title":"Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders","volume":"78","author":"de Melo","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0009","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/schbul\/sby164","article-title":"Schizophrenia is associated with an aberrant immune response to Epstein-Barr virus","volume":"45","author":"Dickerson","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2019.11.150_bib0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archpsyc.60.5.466","article-title":"Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia","volume":"60","author":"Dickerson","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jad.2019.11.150_bib0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0013","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/jid.2013.423","article-title":"Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma","volume":"134","author":"Farina","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jad.2019.11.150_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","article-title":"Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes","volume":"19","author":"Farina","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jad.2019.11.150_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2014.139","article-title":"The link between multiple sclerosis and depression","volume":"10","author":"Feinstein","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jad.2019.11.150_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.psyneuen.2017.09.009","article-title":"Depressive symptoms are associated with salivary shedding of Epstein-Barr virus in female adolescents: the role of sex differences","volume":"86","author":"Ford","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2019.11.150_bib0017","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1099\/jgv.0.000891","article-title":"Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers","volume":"98","author":"Goswami","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0018","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/clinids\/13.Supplement_1.S45","article-title":"Cognitive and mood-state changes in patients with chronic fatigue syndrome","volume":"13","author":"Grafman","year":"1991","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jad.2019.11.150_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2353\/jmoldx.2008.080023","article-title":"Laboratory assays for Epstein-Barr virus-related disease","volume":"10","author":"Gulley","year":"2008","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.jad.2019.11.150_bib0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.oraloncology.2019.04.024","article-title":"Intermittent abortive reactivation of Epstein-Barr virus during the progression of nasopharyngeal cancer as indicated by elevated antibody levels","volume":"93","author":"Guo","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.jad.2019.11.150_bib0021","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/AOG.0b013e31820f3a30","article-title":"Maternal depression and Epstein-Barr virus reactivation in early pregnancy","volume":"117","author":"Haeri","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jad.2019.11.150_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192109","article-title":"Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells","volume":"13","author":"Hassani","year":"2018","journal-title":"PloS One"},{"issue":"14","key":"10.1016\/j.jad.2019.11.150_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00262-18","article-title":"A screen for Epstein-Barr virus proteins that inhibit the DNA damage response reveals a novel histone binding protein","volume":"92","author":"Ho","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0024","first-page":"102332","article-title":"Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model","volume":"9","author":"Jog","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jad.2019.11.150_bib0025","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1073\/pnas.0407320101","article-title":"Proteins of purified Epstein-Barr virus","volume":"101","author":"Johannsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2019.11.150_bib0026","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2019.11.150_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2014.05.019","article-title":"Childhood Epstein-Barr virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study","volume":"158","author":"Khandaker","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2019.11.150_bib0028","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.1986.00520020072025","article-title":"Unusual acute neurologic presentations with Epstein-Barr virus infection","volume":"43","author":"Leavell","year":"1986","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jad.2019.11.150_bib0029","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/19485565.2014.952705","article-title":"A polygenic risk score associated with measures of depressive symptoms among older adults","volume":"60","author":"Levine","year":"2014","journal-title":"Biodemogr. Soc. Biol."},{"key":"10.1016\/j.jad.2019.11.150_bib0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/jvi.53.3.793-799.1985","article-title":"Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody","volume":"53","author":"Lin","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molimm.2015.11.007","article-title":"Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L","volume":"69","author":"Lindsey","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jad.2019.11.150_bib0032","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/infdis\/jiy122","article-title":"Patterns of interindividual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome","volume":"217","author":"Liu","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jad.2019.11.150_bib0033","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fpsyt.2015.00068","article-title":"Gene-environment interaction in major depression: focus on experience-dependent biological systems","volume":"6","author":"Lopizzo","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0034","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-0327(91)90060-6","article-title":"Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients","volume":"21","author":"Maes","year":"1991","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.11.150_bib0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2334-11-281","article-title":"Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid","volume":"11","author":"Martelius","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"23","key":"10.1016\/j.jad.2019.11.150_bib0036","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00975-17","article-title":"Epstein-Barr virus BKRF4 gene product is required for efficient progeny production","volume":"91","author":"Masud","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0037","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4088\/JCP.11r07425","article-title":"Psychiatric symptoms in systemic lupus erythematosus: a systematic review","volume":"73","author":"Meszaros","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0038","first-page":"289","article-title":"Epstein-Barr virus-specific humoral immune responses in health and disease","volume":"391","author":"Middeldorp","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.jad.2019.11.150_bib0039","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1002\/jmv.23713","article-title":"Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome","volume":"85","author":"Montoya","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Murata","year":"2014","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.jad.2019.11.150_bib0041","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jnnp-2016-315367","article-title":"Neuropsychiatric syndromes of multiple sclerosis","volume":"88","author":"Murphy","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2019.11.150_bib0042","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM197606172942501","article-title":"Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx","volume":"294","author":"Niederman","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2019.11.150_bib0043","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The repeatable battery for the assessment of neuropsychological status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.jad.2019.11.150_bib0044","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/schbul\/sbp052","article-title":"Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms","volume":"37","author":"Severance","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jad.2019.11.150_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1212\/WNL.0b013e31823ed057","article-title":"Association of innate immune activation with latent Epstein-Barr virus in active MS lesions","volume":"78","author":"Tzartos","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jad.2019.11.150_bib0046","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1038\/srep03096","article-title":"Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy","volume":"3","author":"Zhu","year":"2013","journal-title":"Sci. Rep."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719326308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719326308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:34:41Z","timestamp":1759023281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719326308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":46,"alternative-id":["S0165032719326308"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.11.150","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical immune response to Epstein-Barr virus in major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.11.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}